This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...